HomeCompareVDRFF vs MRK

VDRFF vs MRK: Dividend Comparison 2026

VDRFF yields 1.69% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VDRFF wins by $79.3K in total portfolio value· pulled ahead in Year 5
10 years
VDRFF
VDRFF
● Live price
1.69%
Share price
$110.43
Annual div
$1.87
5Y div CAGR
53.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$110.1K
Annual income
$42,480.05
Full VDRFF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — VDRFF vs MRK

📍 VDRFF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVDRFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VDRFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VDRFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VDRFF
Annual income on $10K today (after 15% tax)
$143.74/yr
After 10yr DRIP, annual income (after tax)
$36,108.04/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, VDRFF beats the other by $35,300.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VDRFF + MRK for your $10,000?

VDRFF: 50%MRK: 50%
100% MRK50/50100% VDRFF
Portfolio after 10yr
$70.4K
Annual income
$21,715.17/yr
Blended yield
30.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VDRFF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
5.8
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VDRFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVDRFFMRK
Forward yield1.69%3.25%
Annual dividend / share$1.87$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR53.6%8.2%
Portfolio after 10y$110.1K$30.7K
Annual income after 10y$42,480.05$950.29
Total dividends collected$83.5K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: VDRFF vs MRK ($10,000, DRIP)

YearVDRFF PortfolioVDRFF Income/yrMRK PortfolioMRK Income/yrGap
1$10,960$259.76$11,192$351.54$232.00MRK
2$12,136$408.67$12,524$392.70$388.00MRK
3$13,635$649.59$14,015$438.65$380.00MRK
4$15,637$1,047.69$15,682$489.96$45.00MRK
5← crossover$18,456$1,724.81$17,547$547.23+$909.00VDRFF
6$22,671$2,922.43$19,632$611.16+$3.0KVDRFF
7$29,411$5,153.13$21,963$682.53+$7.4KVDRFF
8$41,066$9,596.66$24,571$762.18+$16.5KVDRFF
9$63,176$19,235.62$27,486$851.08+$35.7KVDRFF
10$110,079$42,480.05$30,745$950.29+$79.3KVDRFF

VDRFF vs MRK: Complete Analysis 2026

VDRFFStock

Vidrala, S.A., a consumer packaging company, manufactures and sells glass containers for food and beverage products in Spain, the United Kingdom, Ireland, France, Italy, Portugal, and internationally. The company provides glass oil bottles and vinegar bottles, beer bottles, preserve food jars, cider bottles and sparkling wine bottles, spirit bottles, wine glass bottles, and juice bottles, as well as bottles for non-alcoholic beverages. It also offers packaging services, such as logistic solutions and beverage filling. The company was incorporated in 1965 and is headquartered in Laudio/Llodio, Spain.

Full VDRFF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this VDRFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VDRFF vs SCHDVDRFF vs JEPIVDRFF vs OVDRFF vs KOVDRFF vs MAINVDRFF vs JNJVDRFF vs ABBVVDRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.